FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

Friday, August 17, 2018 1 min read

Key Takeaway: FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration

Full Press Release Details

FDA Approves EYLEA® (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration.